These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 8328496)

  • 1. Fludarabine therapy in Waldenström's macroglobulinemia.
    Dimopoulos MA; O'Brien S; Kantarjian H; Pierce S; Delasalle K; Barlogie B; Alexanian R; Keating MJ
    Am J Med; 1993 Jul; 95(1):49-52. PubMed ID: 8328496
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fludarabine treatment in resistant Waldenstrom's macroglobulinemia.
    Zinzani PL; Gherlinzoni F; Bendandi M; Zaccaria A; Aitini E; Salvucci M; Tura S
    Eur J Haematol; 1995 Feb; 54(2):120-3. PubMed ID: 7698295
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment of Waldenstrom's macroglobulinemia with nucleoside analogues.
    Dimopoulos MA; O'Brien S; Kantarjian H; Estey EE; Keating MJ; Alexanian R
    Leuk Lymphoma; 1993; 11 Suppl 2():105-8. PubMed ID: 7907250
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fludarabine combination therapy is highly effective in first-line and salvage treatment of patients with Waldenström's macroglobulinemia.
    Tam CS; Wolf MM; Westerman D; Januszewicz EH; Prince HM; Seymour JF
    Clin Lymphoma Myeloma; 2005 Sep; 6(2):136-9. PubMed ID: 16231852
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fludarabine in Waldenstrom's macroglobulinemia.
    Leblond V; Choquet S
    Semin Oncol; 2003 Apr; 30(2):239-42. PubMed ID: 12720144
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fludarabine-based combination therapies for Waldenström's macroglobulinemia.
    Tedeschi A; Alamos SM; Ricci F; Greco A; Morra E
    Clin Lymphoma Myeloma; 2009 Mar; 9(1):67-70. PubMed ID: 19362977
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fludarabine in Waldenstrom's macroglobulinemia.
    Souchet-Compain L; Nguyen S; Choquet S; Leblond V
    Expert Rev Hematol; 2013 Jun; 6(3):229-37. PubMed ID: 23782076
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fludarabine therapy in a patient with progressive symptomatic Waldenström's macroglobulinemia.
    Hałaburda K; Hellmann A
    Acta Haematol Pol; 1994; 25(1):63-7. PubMed ID: 8209618
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Purine analogs in chronic lymphocytic leukemia and Waldenström's macroglobulinemia.
    O'Brien S; Kantarjian H; Keating MJ
    Ann Oncol; 1996; 7 Suppl 6():S27-33. PubMed ID: 9010576
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 2Chlorodeoxyadenosine therapy of patients with Waldenström macroglobulinemia previously treated with fludarabine.
    Dimopoulos MA; Weber DM; Kantarjian H; Keating M; Alexanian R
    Ann Oncol; 1994 Mar; 5(3):288-9. PubMed ID: 7514439
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Activity of fludarabine in previously treated Waldenström's macroglobulinemia: a report of 71 cases. Groupe Coopératif Macroglobulinémie.
    Leblond V; Ben-Othman T; Deconinck E; Taksin AL; Harousseau JL; Delgado MA; Delmer A; Maloisel F; Mariette X; Morel P; Clauvel JP; Duboisset P; Entezam S; Hermine O; Merlet M; Yakoub-Agha I; Guibon O; Caspard H; Fort N
    J Clin Oncol; 1998 Jun; 16(6):2060-4. PubMed ID: 9626204
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Phase III study of chlorambucil versus fludarabine as initial therapy for Waldenstrom's macroglobulinemia and related disorders.
    Johnson SA; Owen RG; Oscier DG; Leblond V; Levy V; Jaeger U; Seymour JF
    Clin Lymphoma; 2005 Mar; 5(4):294-7. PubMed ID: 15794869
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fludarabine therapy in Waldenström's macroglobulinemia.
    Thalhammer-Scherrer R; Geissler K; Schwarzinger I; Chott A; Gisslinger H; Knöbl P; Lechner K; Jäger U
    Ann Hematol; 2000 Oct; 79(10):556-9. PubMed ID: 11100745
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment of Waldenstrom's macroglobulinemia with the combination of fludarabine and cyclophosphamide.
    Dimopoulos MA; Hamilos G; Efstathiou E; Siapkaras I; Matsouka C; Gika D; Grigoraki V; Papadimitriou C; Mitsibounas D; Anagnostopoulos N
    Leuk Lymphoma; 2003 Jun; 44(6):993-6. PubMed ID: 12854900
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cryptococcal meningitis and intracranial tuberculoma in a patient with Waldenstrom's macroglobulinemia treated with fludarabine.
    Costa P; Luzzati R; Nicolato A; Perboni G; Scalzini A; Lazzarini L; Forghieri ME; Aitini E; Zinzani PL
    Leuk Lymphoma; 1998 Feb; 28(5-6):617-20. PubMed ID: 9613995
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fludarabine, cyclophosphamide, and rituximab in salvage therapy of Waldenström's macroglobulinemia.
    Tedeschi A; Ricci F; Goldaniga MC; Benevolo G; Varettoni M; Motta M; Pioltelli P; Gini G; Barate' C; Luraschi A; Vismara E; Frustaci AM; Nichelatti M; Vitolo U; Baldini L; Morra E
    Clin Lymphoma Myeloma Leuk; 2013 Apr; 13(2):231-4. PubMed ID: 23490992
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rituximab-based treatments in Waldenström's macroglobulinemia.
    Dimopoulos MA; Kastritis E; Roussou M; Eleutherakis-Papaiakovou E; Migkou M; Gavriatopoulou M; Tassidou A; Terpos E
    Clin Lymphoma Myeloma; 2009 Mar; 9(1):59-61. PubMed ID: 19362975
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Delayed response to fludarabine in lymphoplasmacytic lymphoma/Waldenström's macroglobulinemia.
    Del Giudice I; Matutes E; Osuji N; Parry-Jones N; Swansbury J; Catovsky D
    Haematologica; 2005 Feb; 90(2):268-70. PubMed ID: 15710588
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic factors and response to fludarabine therapy in Waldenstrom's macroglobulinemia: an update of a US intergroup trial (SW0G S9003).
    Dhodapkar MV; Jacobson JL; Gertz MA; Crowley JJ; Barlogie B
    Semin Oncol; 2003 Apr; 30(2):220-5. PubMed ID: 12720140
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Multicenter phase II study of fludarabine phosphate for patients with newly diagnosed lymphoplasmacytoid lymphoma, Waldenström's macroglobulinemia, and mantle-cell lymphoma.
    Foran JM; Rohatiner AZ; Coiffier B; Barbui T; Johnson SA; Hiddemann W; Radford JA; Norton AJ; Tollerfield SM; Wilson MP; Lister TA
    J Clin Oncol; 1999 Feb; 17(2):546-53. PubMed ID: 10080598
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.